Q fever clinics

Q fever clinics may help to streamline testing (skin and serology tests to detect current immunity) and vaccination of appropriate patients. Healthcare professionals may initiate their own clinic or refer to one already established. The Australian Q fever Register www.qfever.org can direct you to a list of Q-VAX® Vaccine providers. However, doctors don’t need to be on one of these lists to be able to provide the vaccine.

Suggestion of Q fever Clinic set-up for patients that have been screened as potential vaccinees:


Q fever Clinic Initiating Tests

First: assess the patient’s risk of previous exposure to Q fever by taking a detailed history. This can include:

  • any previous vaccination with Q-VAX® vaccine
  • a history of likely exposure to Coxiella burnetii followed by an illness strongly suggestive of Q fever
  • any hypersensitivity to egg proteins or any other known allergies

If the patient is unlikely to have prior sensitisation to Q fever antigens based on the detailed history. Then:

Second: take patient’s blood sample for serology testing.

Third: inject 0.1 mL of diluted Q-VAX® skin test solution intradermally into the volar surface of the mid-forearm.1

Schedule an appointment with the patient 7 days later to interpret the results of the skin test.1

Note: Q-VAX® skin test solution supplied (0.5 mL) is made up to 15 mL by adding 14.5 mL saline (sodium chloride solution). Since only 0.1 mL is used per patient, one vial of the skin test can be used for multiple patients (up to 150) providing it is stored at 4°C and used within 6 hours of preparation.1


* If the blood test or skin test result is ambiguous, refer to the Australian Immunisation Handbook for advice about how to interpret the finding(s) and the recommended action.2

Seqirus does not endorse the use of Q-VAX® other than as described in the Product Information.

Further resources are available in Educational Resources.

For more detailed information about Q-VAX® Vaccine, as well as the recommended pre-vaccination screening protocol (including the use of Q-VAX® Skin Test), please refer to the Q-VAX® Approved Product Information and the Australian Immunisation Handbook.